Kite Medical Hub

SCROLL

Bitesize Education

Explore expert insights and educational material on CAR T-cell therapy and access up-to-date information on non-Hodgkin lymphoma (NHL). The Kite Medical Hub is a non-promotional website intended for healthcare professionals in the UK and Ireland, designed, built and funded by Kite, a Gilead Company.

eRMM Tool

Welcome to eRMM Tool an interactive training tool on the management of cytokine release syndrome and neurotoxicity in your YESCARTA^® (axicabtagene ciloleucel) CAR T patients.

A CAR T patient avatar will take you on their treatment journey: from preparing your delivery centre, handling and administering treatment to managing any side effects promptly.

Upon completing a quiz at the end, you will be awarded an accredited CPD Certificate.

>>CLICK HERE

Additional monitoring required.

Adverse events should be reported. For the UK, reporting forms and information can be found at https://yellowcard.mhra.gov.uk/or via the Yellow Card app (download from the Apple App Store or Google Play Store). Adverse events should also be reported to Gilead at safety_FC@gilead.com or +44 (0) 1223 897500.

Adverse events should be reported. For Ireland, reporting forms and information can be found at www.hpra.ie and can be reported to HPRA on +353 1 6764971. Adverse events should also be reported to Gilead at safety_FC@gilead.com or +44 (0) 1223 897500.

Latest podcast

See more podcasts

02 Nov 2020

(DURATION: 32:05 - 59 MB)

Patient Perspectives: Long-Term Psycho-Social Impact of CAR T Back in the Community

Mr Stephen Scowcroft discusses the work of Lymphoma Action in wellbeing and education in patients receiving CAR T therapy, including the key role it plays in facilitating the voice of patients affected by lymphoma and how to improve the system going forward.

This podcast is intended for UK & Ireland HCPs who have registered with this Kite-owned website; please do not copy or distribute any content.

Play Podcast

Latest events

See more events

14 Sep 2020

GIO-Med virtual event 2020

Explore highlights from this year’s Gilead Immuno-Oncology Medical Education (GIO-Med) virtual event, broadcast as a series of pre-recorded educational videos and podcasts.

Join leading experts featured in the field of immuno-oncology as they discuss managing patients with diffuse large B-cell lymphoma (DLBCL) in clinical practice.

View event

Abbreviations:
CAR T, chimeric antigen receptor T-cell; DLBCL, diffuse large B-cell lymphoma; HCP, healthcare professional; KCH, King’s College Hospitals; NHL, non-Hodgkin lymphoma; UK, United Kingdom.